Total Payments
$25,857
2024 Payments
$3,283
Companies
41
Transactions
938
Medicare Patients
10,131
Medicare Billing
$814,814
Payment Breakdown by Category
Food & Beverage$19,920 (77.0%)
Other$4,300 (16.6%)
Travel$1,414 (5.5%)
Education$223.55 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,920 | 924 | 77.0% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,800 | 1 | 14.7% |
| Travel and Lodging | $1,414 | 5 | 5.5% |
| Honoraria | $350.00 | 1 | 1.4% |
| Education | $223.55 | 6 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $7,105 | 101 | $0 (2024) |
| ABBVIE INC. | $3,413 | 130 | $0 (2024) |
| GENZYME CORPORATION | $1,804 | 55 | $0 (2024) |
| Janssen Biotech, Inc. | $1,495 | 93 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,475 | 77 | $0 (2024) |
| Lilly USA, LLC | $1,368 | 54 | $0 (2024) |
| Amgen Inc. | $925.31 | 34 | $0 (2024) |
| MAYNE PHARMA INC. | $773.31 | 48 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $712.51 | 28 | $0 (2024) |
| Biofrontera Inc. | $702.09 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,283 | 148 | ABBVIE INC. ($577.07) |
| 2023 | $3,650 | 172 | Lilly USA, LLC ($449.56) |
| 2022 | $3,344 | 170 | ABBVIE INC. ($545.76) |
| 2021 | $1,941 | 103 | AbbVie Inc. ($340.16) |
| 2020 | $1,591 | 68 | AbbVie Inc. ($344.59) |
| 2019 | $2,130 | 99 | AbbVie, Inc. ($390.53) |
| 2018 | $1,829 | 78 | AbbVie, Inc. ($514.39) |
| 2017 | $8,089 | 100 | Novartis Pharmaceuticals Corporation ($5,412) |
All Payment Transactions
938 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.64 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/18/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $7.73 | General |
| 12/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.99 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: DERMATOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $3.53 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $30.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $18.81 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $4.37 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: DERMATOLOGY | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $8.00 | General |
| 11/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $44.32 | General |
| Category: Immunology | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: DERMATOLOGY | ||||||
| 11/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/30/2024 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $18.98 | General |
| Category: DERMATOLOGY | ||||||
| 10/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $40.42 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $2.30 | General |
| 10/16/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $23.76 | General |
| Category: Dermatology | ||||||
| 10/15/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.43 | General |
| 10/10/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $27.40 | General |
| Category: Dermatology | ||||||
| 10/09/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.60 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,697 | 9,783 | $511,901 | $220,739 |
| 2022 | 21 | 2,644 | 9,457 | $518,074 | $217,129 |
| 2021 | 21 | 2,466 | 14,566 | $480,449 | $211,263 |
| 2020 | 21 | 2,324 | 11,557 | $412,527 | $165,683 |
Total Patients
10,131
Total Services
45,363
Medicare Billing
$814,814
Procedure Codes
84
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 723 | 1,079 | $107,900 | $66,350 | 61.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 299 | 369 | $64,575 | $29,224 | 45.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 296 | 350 | $56,000 | $21,680 | 38.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 408 | 558 | $64,170 | $20,187 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 210 | $32,550 | $18,055 | 55.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 168 | 168 | $30,240 | $11,611 | 38.4% |
| 12031 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.5 cm or less | Office | 2023 | 38 | 44 | $14,300 | $7,926 | 55.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 282 | 1,490 | $44,700 | $6,725 | 15.0% |
| 96574 | Application of light with debridement to destroy precancer skin growth | Office | 2023 | 26 | 27 | $12,960 | $6,168 | 47.6% |
| J7345 | Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg | Office | 2023 | 26 | 5,201 | $12,586 | $5,057 | 40.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 37 | 43 | $15,480 | $4,757 | 30.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 19 | 21 | $7,875 | $3,737 | 47.5% |
| 12051 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.5 cm or less | Office | 2023 | 15 | 15 | $6,375 | $3,336 | 52.3% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 17 | 18 | $8,100 | $3,184 | 39.3% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 28 | 31 | $10,850 | $3,117 | 28.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 53 | 65 | $4,550 | $2,590 | 56.9% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 16 | 16 | $6,960 | $1,898 | 27.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $2,940 | $1,590 | 54.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 37 | 40 | $3,200 | $1,589 | 49.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,250 | $1,333 | 41.0% |
| 69100 | Biopsy of ear | Office | 2023 | 13 | 13 | $2,340 | $625.22 | 26.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 657 | 975 | $100,345 | $56,663 | 56.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 334 | 396 | $63,496 | $26,904 | 42.4% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 244 | 293 | $51,608 | $23,585 | 45.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 410 | 571 | $65,683 | $20,723 | 31.6% |
About Dr. Betty Rajan, M.D
Dr. Betty Rajan, M.D is a Dermatology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396793311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Betty Rajan, M.D has received a total of $25,857 in payments from pharmaceutical and medical device companies, with $3,283 received in 2024. These payments were reported across 938 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($19,920).
As a Medicare-enrolled provider, Rajan has provided services to 10,131 Medicare beneficiaries, totaling 45,363 services with total Medicare billing of $814,814. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Fort Worth, TX
- Active Since 05/04/2006
- Last Updated 09/08/2011
- Taxonomy Code 207N00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396793311
Products in Payments
- COSENTYX (Biological) $6,356
- DUPIXENT (Biological) $1,879
- SKYRIZI (Biological) $1,515
- TALTZ (Drug) $1,225
- Otezla (Drug) $1,084
- Humira (Biological) $822.94
- TREMFYA (Drug) $806.50
- COSENTYX (Drug) $694.36
- VTAMA (Drug) $633.06
- Ameluz (Drug) $588.29
- DORYX (Drug) $462.72
- REMICADE (Biological) $440.83
- EUCRISA (Drug) $417.99
- HUMIRA (Biological) $311.71
- ADBRY (Biological) $311.29
- OPZELURA (Drug) $296.72
- Sotyktu (Drug) $292.90
- ENSTILAR (Drug) $273.69
- RINVOQ (Biological) $249.20
- DUPIXENT (Drug) $233.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Fort Worth
Dr. Patrick Keehan, D.o, D.O
Dermatology — Payments: $761,024
Dermatology $761,024
Dr. Ronald Plott, M.d, M.D
Dermatology — Payments: $467,637
Dermatology $467,637
William Cothern, Do, DO
Dermatology — Payments: $41,403
Dermatology $41,403
Stephen Weis, Do, DO
Dermatology — Payments: $32,162
Dermatology $32,162
Kathryn Durham, Md, MD
Dermatology — Payments: $28,437
Dermatology $28,437
Dr. James Mccarty, M.d, M.D
Dermatology — Payments: $20,110
Dermatology $20,110